Literature DB >> 10353435

Reduced satiating effect of d-fenfluramine in serotonin 5-HT(2C) receptor mutant mice.

S P Vickers1, P G Clifton, C T Dourish, L H Tecott.   

Abstract

RATIONALE: d-Fenfluramine stimulates the release of serotonin (5-HT) and is a potent inhibitor of the re-uptake of 5-HT into nerve terminals. Administration of d-fenfluramine suppresses food intake in both animals and humans.
OBJECTIVE: We have investigated the role of the 5-HT2C receptor in mediating the effect of d-fenfluramine on mouse food intake and the behavioural satiety sequence.
METHODS: Mutant mice lacking serotonin 5-HT2C receptors and wild-type animals were habituated to a daily presentation of wet mash. Animals were non-deprived and received d-fenfluramine (3-30 mg/kg) 30 min prior to being assessed for the presence of stereotypy and presented with wet mash. The behaviour of animals was observed for the subsequent 40 min and food intake was recorded.
RESULTS: d-Fenfluramine dose-dependently inhibited the consumption of a palatable wet mash by the mice. d-Fenfluramine (3 mg/kg) significantly reduced the amount of wet mash consumed by wild-type mice and induced a temporal advance in the behavioural satiety sequence consistent with an enhancement of satiety. Mutant mice were less sensitive to the satiating effects of 3 mg/kg d-fenfluramine. Hence, this dose of d-fenfluramine had a reduced effect on both food consumption and the behavioural satiety sequence in the 5-HT2C mutant mice. In contrast, mutant mice showed an increased sensitivity to the stereotypy induced by high doses of d-fenfluramine (10, 30 mg/kg) compared to that of wild-type littermates.
CONCLUSION: These data demonstrate a role for the 5-HT2C receptor in mediating d-fenfluramine-induced satiety.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10353435     DOI: 10.1007/s002130050952

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  65 in total

1.  Deconstructing antiobesity compound action: requirement of serotonin 5-HT2B receptors for dexfenfluramine anorectic effects.

Authors:  Sophie M Banas; Stéphane Doly; Katia Boutourlinsky; Silvina L Diaz; Arnauld Belmer; Jacques Callebert; Corinne Collet; Jean-Marie Launay; Luc Maroteaux
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

2.  Serotonin 2C receptor activates a distinct population of arcuate pro-opiomelanocortin neurons via TRPC channels.

Authors:  Jong-Woo Sohn; Yong Xu; Juli E Jones; Kevin Wickman; Kevin W Williams; Joel K Elmquist
Journal:  Neuron       Date:  2011-08-11       Impact factor: 17.173

3.  Enterostatin inhibition of dietary fat intake is modulated through the melanocortin system.

Authors:  Ling Lin; Miejung Park; David A York
Journal:  Peptides       Date:  2006-11-17       Impact factor: 3.750

Review 4.  A short history of the 5-HT2C receptor: from the choroid plexus to depression, obesity and addiction treatment.

Authors:  Jose M Palacios; Angel Pazos; Daniel Hoyer
Journal:  Psychopharmacology (Berl)       Date:  2017-03-07       Impact factor: 4.530

Review 5.  Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.

Authors:  Jason C G Halford; Joanne A Harrold; Emma J Boyland; Clare L Lawton; John E Blundell
Journal:  Drugs       Date:  2007       Impact factor: 9.546

6.  Effects of lorcaserin and buspirone, administered alone and as a mixture, on cocaine self-administration in male and female rhesus monkeys.

Authors:  Gregory T Collins; Charles P France
Journal:  Exp Clin Psychopharmacol       Date:  2018-06-28       Impact factor: 3.157

7.  A serotonin and melanocortin circuit mediates D-fenfluramine anorexia.

Authors:  Yong Xu; Juli E Jones; Danielle A Lauzon; Jason G Anderson; Nina Balthasar; Lora K Heisler; Andrew R Zinn; Bradford B Lowell; Joel K Elmquist
Journal:  J Neurosci       Date:  2010-11-03       Impact factor: 6.167

8.  Mice overexpressing the 5-hydroxytryptamine transporter show no alterations in feeding behaviour and increased non-feeding responses to fenfluramine.

Authors:  A Pringle; K A Jennings; S Line; D M Bannerman; S Higgs; T Sharp
Journal:  Psychopharmacology (Berl)       Date:  2008-06-16       Impact factor: 4.530

9.  Aripiprazole added to overweight and obese olanzapine-treated schizophrenia patients.

Authors:  David C Henderson; Xiaoduo Fan; Paul M Copeland; Bikash Sharma; Christina P Borba; Ryan Boxill; Oliver Freudenreich; Corinne Cather; A Eden Evins; Donald C Goff
Journal:  J Clin Psychopharmacol       Date:  2009-04       Impact factor: 3.153

10.  Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.

Authors:  Antony R Knight; Anil Misra; Kathleen Quirk; Karen Benwell; Dean Revell; Guy Kennett; Mike Bickerdike
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2004-07-30       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.